These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2609642)

  • 21. Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees.
    Alexandrova GI; Polezhaev FI; Budilovsky GN; Garmashova LM; Topuria NA; Egorov AY; Romejko-Gurko YR; Koval TA; Lisovskaya KV; Klimov AI
    Infect Immun; 1984 Jun; 44(3):734-9. PubMed ID: 6724695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
    Keitel WA; Couch RB; Cate TR; Six HR; Baxter BD
    J Infect Dis; 1990 Jan; 161(1):22-6. PubMed ID: 2153185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
    Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
    Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antigenic characteristics of influenza B virus strains isolated in an orphanage during an influenza outbreak in Moscow in the winter of 1988].
    Reĭzin FN; Mart'ianova LI; Malyshkina LP; Chumakov MP
    Vopr Virusol; 1989; 34(5):562-4. PubMed ID: 2609641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.
    Steinhoff MC; Halsey NA; Fries LF; Wilson MH; King J; Burns BA; Samorodin RK; Perkis V; Murphy BR; Clements ML
    J Infect Dis; 1991 May; 163(5):1023-8. PubMed ID: 2019751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
    Chan W; Zhou H; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of cold-adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic polymerase (PA) protein gene confers temperature sensitivity and attenuated virulence.
    Donabedian AM; DeBorde DC; Maassab HF
    Microb Pathog; 1987 Aug; 3(2):97-108. PubMed ID: 3504545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.
    Murphy BR; Chanock RM; Clements ML; Anthony WC; Sear AJ; Cisneros LA; Rennels MB; Miller EH; Black RE; Levine MM; Betts RF; Douglas RG; Maassab HF; Cox NJ; Kendal AP
    Infect Immun; 1981 May; 32(2):693-7. PubMed ID: 7251144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Drieszen-van der Cruijsen SK; Basten SM; Heldens JG; van den Bosch H; Rudenko LG
    J Gen Virol; 2010 Apr; 91(Pt 4):931-7. PubMed ID: 20007357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
    Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
    Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines.
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):354-62. PubMed ID: 18804834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults.
    Treanor J; Dumyati G; O'Brien D; Riley MA; Riley G; Erb S; Betts R
    J Infect Dis; 1994 Feb; 169(2):402-7. PubMed ID: 8106775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live bivalent vaccine for parainfluenza and influenza virus infections.
    Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
    J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.